Results 141 to 150 of about 2,141 (187)

PCR-confirmed severe geographic HSV-1 keratitis associated with systemic JAK inhibitor therapy. [PDF]

J Ophthalmic Inflamm Infect
Roels D, Kreps EO, Houben I, Delie A, Lapeere H, Leroy BP, Claerhout I, Kerre T.   +7 more
europepmc   +1 more source

Corrigendum to "Retrospective analysis of the efficacy and safety of 100 mg abrocitinib in patients with moderate to severe atopic dermatitis: Real-world study" [World Allergy Organ J 16 (2) (2023) 101167]. [PDF]

World Allergy Organ J
Li M, Lian C, Wang X.
europepmc   +1 more source

The JAK-STAT pathway in allergic diseases: from pathogenesis to targeted therapy. [PDF]

Biomark Res
Chen Y, Hu J, Liu X, Zhou W, Zhong B, Liu F.   +5 more
europepmc   +1 more source

Risk assessment of asthma and allergic rhinitis in atopic dermatitis patients treated with biologics and JAK inhibitors: a systematic review and network meta-analysis of randomized controlled trials. [PDF]

BMC Med
Zeng L, Zhou T, Zhang L, Xian M, Zhu Z, Liu J, Fu S, Luo H, Li J.   +8 more
europepmc   +1 more source

Efficacy of Abrocitinib and Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis Using Treat-to-Target Goals Recommended by Experts in China.

Int Arch Allergy Immunol
Zhao Z, Gao XH, Ding Y, Liu H, Weidinger S, Pan S, Li S, Luo X, Feeney C, Watkins M, Arumugam M.   +10 more
europepmc   +1 more source

Rapid resolution of refractory cutaneous lichen planus with abrocitinib. [PDF]

JAAD Case Rep
Ho A, Goldberg R, Hamann CR.
europepmc   +1 more source

Review on the Application of Biologic Factors in Atopic Dermatitis and Chronic Spontaneous Urticaria. [PDF]

Dermatol Res Pract
Salavoura A.
europepmc   +1 more source

Successful Treatment of Concurrent Bullous Pemphigoid and Psoriasis Vulgaris with Abrocitinib: A Case Report and Literature Review. [PDF]

Clin Cosmet Investig Dermatol
Hu YQ, Zhang JZ, Zhao Y.
europepmc   +1 more source

Off-label use of abrocitinib in dermatology: A systematic literature review with narrative summary. [PDF]

JAAD Int
Su Z, Sun C, Yao WH, Wang P, Zeng YP.
europepmc   +1 more source